Norberto Perico
#137,020
Most Influential Person Now
Norberto Perico's AcademicInfluence.com Rankings
Norberto Pericomedical Degrees
Medical
#2395
World Rank
#2817
Historical Rank
Epidemiology
#430
World Rank
#450
Historical Rank

Download Badge
Medical
Why Is Norberto Perico Influential?
(Suggest an Edit or Addition)Norberto Perico's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012) (11746)
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012) (8152)
- Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012) (7185)
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) (5789)
- Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015) (5270)
- Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2015) (4436)
- Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (4388)
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (4293)
- Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (2020) (4169)
- Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013 (2015) (4152)
- Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) (3330)
- Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) (3308)
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019 (2020) (2362)
- Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) (1869)
- Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2020) (1788)
- Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition (2015) (1618)
- Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (1580)
- Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) (1515)
- Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2019) (1485)
- Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) (1477)
- Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015) (1475)
- Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015) (1241)
- Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 (2012) (1159)
- Delayed graft function in kidney transplantation (2004) (929)
- Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. (2004) (748)
- Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (623)
- Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (579)
- Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015 (2016) (549)
- Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) (538)
- Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019 (2020) (522)
- Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) (495)
- Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013: Findings From the Global Burden of Disease 2013 Study. (2016) (475)
- Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015 (2017) (452)
- Pretransplant Infusion of Mesenchymal Stem Cells Prolongs the Survival of a Semiallogeneic Heart Transplant through the Generation of Regulatory T Cells1 (2008) (429)
- The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. (2005) (417)
- Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015 (2016) (394)
- Human Bone Marrow Mesenchymal Stem Cells Accelerate Recovery of Acute Renal Injury and Prolong Survival in Mice (2008) (369)
- Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate. (1995) (341)
- Mechanisms of Disease: pre-eclampsia (2005) (329)
- Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. (2016) (308)
- Five insights from the Global Burden of Disease Study 2019 (2020) (291)
- Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility. (2011) (278)
- Chronic Renal Diseases: Renoprotective Benefits of ReninAngiotensin System Inhibition (2002) (276)
- Regulatory T cells and T cell depletion: role of immunosuppressive drugs. (2007) (246)
- Tumor necrosis factor induces glomerular damage in the rabbit. (1989) (245)
- Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation. (2002) (229)
- Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial (2013) (225)
- Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes. (1993) (223)
- Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. (1993) (220)
- Child and Adolescent Health From 1990 to 2015 (2017) (217)
- Performance of Different Prediction Equations for Estimating Renal Function in Kidney Transplantation (2004) (203)
- Functional significance of exaggerated renal thromboxane A2 synthesis induced by cyclosporin A. (1986) (195)
- von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. (2002) (192)
- Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression. (1993) (186)
- Endothelin mediates the renal vasoconstriction induced by cyclosporine in the rat. (1990) (186)
- Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation. (1992) (169)
- Increased renal endothelin production in rats with reduced renal mass. (1991) (168)
- Recellularization of well-preserved acellular kidney scaffold using embryonic stem cells. (2014) (168)
- Global Cardiovascular and Renal Outcomes of Reduced GFR. (2017) (167)
- Hepatitis C infection and chronic renal diseases. (2009) (166)
- Maintenance Dialysis throughout the World in Years 1990 and 2010. (2015) (163)
- New therapeutics that antagonize endothelin: promises and frustrations (2002) (158)
- Cyclosporine-induced renal dysfunction in experimental animals and humans. (1991) (157)
- Localization of Mesenchymal Stromal Cells Dictates Their Immune or Proinflammatory Effects in Kidney Transplantation (2012) (157)
- Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial (2004) (155)
- Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation (2013) (154)
- Precision of plasma clearance of iohexol for estimation of GFR in patients with renal disease. (1998) (153)
- Disparities in Chronic Kidney Disease Prevalence among Males and Females in 195 Countries: Analysis of the Global Burden of Disease 2016 Study (2018) (150)
- Thymic recognition of class II major histocompatibility complex allopeptides induces donor-specific unresponsiveness to renal allografts. (1993) (141)
- Mechanisms of acquired thymic unresponsiveness to renal allografts. Thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy. (1994) (137)
- Constitutive expression of endothelin gene in cultured human mesangial cells and its modulation by transforming growth factor-beta, thrombin, and a thromboxane A2 analogue. (1991) (133)
- Hemolytic Uremic Syndrome: A Fatal Outcome after Kidney and Liver Transplantation Performed to Correct Factor H Gene Mutation (2005) (129)
- Bone marrow-derived mesenchymal stem cells improve islet graft function in diabetic rats. (2009) (129)
- Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism. (1998) (128)
- Timed urine collections are not needed to measure urine protein excretion in clinical practice. (2006) (125)
- Multipotent Mesenchymal Stromal Cell Therapy and Risk of Malignancies (2013) (124)
- Kidney graft survival in rats without immunosuppressants after intrathymic glomerular transplantation (1991) (121)
- Mesenchymal stromal cells in renal transplantation: opportunities and challenges (2016) (120)
- Sirolimus therapy to halt the progression of ADPKD. (2010) (116)
- Nature and extent of glomerular injury induced by cyclosporine in heart transplant patients. (1991) (116)
- Role of endothelium-derived nitric oxide in the bleeding tendency of uremia. (1990) (115)
- Angiotensin II modulates glomerular capillary permselectivity in rat isolated perfused kidney. (1996) (113)
- Antiproteinuric therapy while preventing the abnormal protein traffic in proximal tubule abrogates protein- and complement-dependent interstitial inflammation in experimental renal disease. (1999) (113)
- Role of Insulin and Atrial Natriuretic Peptide in Sodium Retention in Insulin-Treated IDDM Patients During Isotonic Volume Expansion (1990) (113)
- The aggravating mechanisms of aldosterone on kidney fibrosis. (2008) (111)
- A developmental approach to the prevention of hypertension and kidney disease: a report from the Low Birth Weight and Nephron Number Working Group (2017) (110)
- Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019 (2021) (108)
- Sirolimus Versus Cyclosporine Therapy Increases Circulating Regulatory T Cells, But Does Not Protect Renal Transplant Patients Given Alemtuzumab Induction From Chronic Allograft Injury (2007) (108)
- The Impact of Kidney Development on the Life Course: A Consensus Document for Action (2017) (108)
- A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes (2018) (105)
- ACE inhibition and ANG II receptor blockade improve glomerular size-selectivity in IgA nephropathy. (1999) (101)
- Chronic kidney disease: a research and public health priority. (2012) (98)
- Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year. (1999) (98)
- C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantation. (2007) (94)
- Pharmacokinetics help optimizing mycophenolate mofetil dosing in kidney transplant patients (2001) (93)
- Present and future drug treatments for chronic kidney diseases: evolving targets in renoprotection (2008) (93)
- THE ACUTE EFFECT OF FK506 AND CYCLOSPORINE ON ENDOTHELIAL CELL FUNCTION AND RENAL VASCULAR RESISTANCE (1992) (92)
- Application of newer clearance techniques for the determination of glomerular filtration rate. (1998) (92)
- Predicting Cisplatin-Induced Acute Kidney Injury by Urinary Neutrophil Gelatinase-Associated Lipocalin Excretion: A Pilot Prospective Case-Control Study (2010) (90)
- The antiproteinuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacin. (1998) (85)
- Influence of Co‐Medication with Sirolimus or Cyclosporine on Mycophenolic Acid Pharmacokinetics in Kidney Transplantation (2005) (83)
- Nephrotoxic aspects of cyclosporine. (2004) (79)
- Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT). (2010) (78)
- Effect of short-term cyclosporine administration in rats on renin-angiotensin and thromboxane A2: possible relevance to the reduction in glomerular filtration rate. (1986) (77)
- Long-term follow-up of recovered patients with COVID-19 (2021) (76)
- Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Fourth Meeting: Lessons Learned from First Clinical Trials (2013) (75)
- Renal injury induced by long-term administration of cyclosporin A to rats. (1987) (73)
- Mesenchymal stromal cells to promote solid organ transplantation tolerance (2013) (72)
- Evidence that an angiotensin-converting enzyme inhibitor has a different effect on glomerular injury according to the different phase of the disease at which the treatment is started. (1994) (72)
- Acute cyclosporine A nephrotoxicity in rats: which role for renin-angiotensin system and glomerular prostaglandins? (1986) (72)
- Propionyl-L-carnitine prevents renal function deterioration due to ischemia/reperfusion. (2002) (71)
- The global distribution of lymphatic filariasis, 2000–18: a geospatial analysis (2020) (70)
- Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicity. (1988) (70)
- Toward MSC in Solid Organ Transplantation: 2008 Position Paper of the MISOT Study Group (2009) (70)
- ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy. (1999) (70)
- From Pharmacokinetics to Pharmacogenomics: A New Approach to Tailor Immunosuppressive Therapy (2004) (70)
- Burden of CKD, proteinuria, and cardiovascular risk among Chinese, Mongolian, and Nepalese participants in the International Society of Nephrology screening programs. (2010) (69)
- ABCB1 genotypes predict cyclosporine-related adverse events and kidney allograft outcome. (2009) (69)
- Strategies for national health care systems in emerging countries: the case of screening and prevention of renal disease progression in Bolivia. (2005) (69)
- Prevention programmes of progressive renal disease in developing nations (Review Article) (2006) (69)
- Endothelin induces diuresis and natriuresis in the rat by acting on proximal tubular cells through a mechanism mediated by lipoxygenase products. (1991) (67)
- Long‐Term Renal Allograft Function on a Tacrolimus‐Based, Pred‐Free Maintenance Immunosuppression Comparing Sirolimus vs. MMF † (2006) (67)
- Glomerular filtration rate determined from a single plasma sample after intravenous iohexol injection: is it reliable? (1996) (65)
- In Kidney Transplant Patients, Alemtuzumab but Not Basiliximab/Low-Dose Rabbit Anti-Thymocyte Globulin Induces B Cell Depletion and Regeneration, Which Associates with a High Incidence of De Novo Donor-Specific Anti-HLA Antibody Development (2013) (65)
- Blunted excretory response to atrial natriuretic peptide in experimental nephrosis. (1989) (65)
- Whole-blood calcineurin activity is not predicted by cyclosporine blood concentration in renal transplant recipients. (2001) (63)
- Prediction of cyclosporine area under the curve using a three-point sampling strategy after Neoral administration. (1997) (63)
- Colchicine interferes with L-selectin and leukocyte function-associated antigen-1 expression on human T lymphocytes and inhibits T cell activation. (1996) (62)
- Measuring and Estimating GFR and Treatment Effect in ADPKD Patients: Results and Implications of a Longitudinal Cohort Study (2012) (62)
- Therapeutic Drug Monitoring of Sirolimus: Effect of Concomitant Immunosuppressive Therapy and Optimization of Drug Dosing (2004) (61)
- Paricalcitol for secondary hyperparathyroidism in renal transplantation. (2015) (61)
- Nature and mediators of parietal epithelial cell activation in glomerulonephritides of human and rat. (2013) (60)
- Community-based screening for chronic kidney disease, hypertension and diabetes in Dharan. (2013) (59)
- Measurement of glomerular filtration rate. (1997) (58)
- Kidney failure: aims for the next 10 years and barriers to success (2013) (57)
- V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction. (2009) (57)
- von Willebrand factor cleaving protease ( ADAMTS 13 ) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome (2002) (56)
- Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 (2022) (54)
- Sequential monitoring of urine-soluble interleukin 2 receptor and interleukin 6 predicts acute rejection of human renal allografts before clinical or laboratory signs of renal dysfunction. (1997) (54)
- PHARMACOKINETICS OF MYCOPHENOLATE SODIUM AND COMPARISON WITH THE MOFETIL FORMULATION IN KIDNEY TRANSPLANT RECIPIENTS. (2006) (54)
- Atrial Natriuretic Peptide and Prostacyclin Synergistically Mediate Hyperfiltration and Hyperperfusion of Diabetic Rats (1992) (54)
- Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000–17 (2020) (52)
- Italy's health performance, 1990–2017: findings from the Global Burden of Disease Study 2017 (2019) (51)
- Tackling the Shortage of Donor Kidneys: How to Use the Best that We Have (2003) (51)
- Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell Immunotherapy (2018) (50)
- INCREASED URINARY EXCRETION OF ENDOTHELIN‐1 AND ITS PRECURSOR, BIG‐ENDOTHELIN-1, IN RATS CHRONICALLY TREATED WITH CYCLOSPORINE (1991) (48)
- Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017 (2020) (47)
- Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000–17: analysis for the Global Burden of Disease Study 2017 (2020) (47)
- Clinical Translation of Mesenchymal Stromal Cell Therapies in Nephrology. (2017) (45)
- Prevention of transplant rejection: current treatment guidelines and future developments. (1997) (45)
- Pharmacogenetics of Immunosuppressants: Progress, Pitfalls and Promises (2008) (44)
- Mapping child growth failure across low- and middle-income countries (2020) (44)
- Peripheral donor leukocytes prolong survival of rat renal allografts. (1999) (44)
- Screening for chronic kidney disease in emerging countries: feasibility and hurdles. (2009) (44)
- Effects of MCP-1 Inhibition by Bindarit Therapy in a Rat Model of Polycystic Kidney Disease (2014) (43)
- Protecting single-kidney allografts from long-term functional deterioration. (1998) (42)
- Renal protective effect of angiotensin-converting enzyme inhibition in aging rats. (1992) (42)
- Cyclosporine induces glomerulosclerosis: three-dimensional definition of the lesions in a rat model of renal transplant. (1996) (42)
- Angiotensin II contributes to diabetic renal dysfunction in rodents and humans via Notch1/Snail pathway. (2013) (41)
- Edema of the nephrotic syndrome: the role of the atrial peptide system. (1993) (40)
- Mesenchymal stromal cells for tolerance induction in organ transplantation. (2017) (39)
- Thromboxane A2 receptor blocking abrogates donor-specific unresponsiveness to renal allografts induced by thymic recognition of major histocompatibility allopeptides (1994) (39)
- Preventing renal and cardiovascular risk by renal function assessment: insights from a cross-sectional study in low-income countries and the USA (2012) (39)
- Targeted deletion of angiotensin II type 1A receptor does not protect mice from progressive nephropathy of overload proteinuria. (2004) (39)
- Measurement of GFR with a single intravenous injection of nonradioactive iothalamate. (1992) (38)
- ACE inhibition limits chronic injury of kidney transplant even with treatment started when lesions are established. (2003) (38)
- A simple, home-therapy algorithm to prevent hospitalisation for COVID-19 patients: A retrospective observational matched-cohort study (2021) (37)
- Toward novel antirejection strategies: in vivo immunosuppressive properties of CTLA4Ig. (1995) (37)
- Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injury. (2012) (36)
- Ways to Boost Kidney Transplant Viability: A Real Need for the Best Use of Older Donors (2006) (36)
- Effects of high dose aleglitazar on renal function in patients with type 2 diabetes. (2011) (36)
- Thromboxane receptor blockade attenuates chronic cyclosporine nephrotoxicity and improves survival in rats with renal isograft. (1992) (36)
- Ticlopidine prevents renal disease progression in rats with reduced renal mass. (1990) (36)
- Combined treatment with mycophenolate mofetil and an angiotensin II receptor antagonist fully protects from chronic rejection in a rat model of renal allograft. (2001) (36)
- L-arginine, the precursor of nitric oxide, abolishes the effect of estrogens on bleeding time in experimental uremia. (1991) (35)
- Role of endothelin in glomerular injury. (1993) (35)
- Effect of platelet-activating factor and its specific receptor antagonist on glomerular permeability to proteins in isolated perfused rat kidney. (1988) (35)
- The thymic way to transplantation tolerance. (1995) (35)
- Effect of Sirolimus on Disease Progression in Patients with Autosomal Dominant Polycystic Kidney Disease and CKD Stages 3b-4. (2016) (34)
- Simultaneous determination of everolimus and cyclosporine concentrations by HPLC with ultraviolet detection. (2006) (34)
- Maternal and environmental risk factors for neonatal AKI and its long-term consequences (2018) (34)
- Preventing end-stage renal disease: the potential impact of screening and intervention in developing countries. (2003) (33)
- Pathophysiology of disease progression in proteinuric nephropathies. (2005) (33)
- Endothelin and eicosanoid synthesis in cultured mesangial cells. (1990) (33)
- High-performance liquid chromatography with ultraviolet detection for therapeutic drug monitoring of everolimus. (2005) (33)
- Enhanced glomerular thromboxane A2 mediates some pathophysiologic effect of platelet-activating factor in rabbit nephrotoxic nephritis: evidence from biochemical measurements and inhibitor trials. (1989) (32)
- Following an initial decline, glomerular filtration rate stabilizes in heart transplant patients on chronic cyclosporine. (1994) (32)
- Thromboxane synthesis inhibition increases renal prostacyclin and prevents renal disease progression in rats with remnant kidney. (1990) (32)
- Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial (2019) (32)
- Xenotransplantation: problems and prospects. (1997) (31)
- Role of enhanced glomerular synthesis of thromboxane A2 in progressive kidney disease. (1990) (30)
- Mapping disparities in education across low- and middle-income countries (2019) (30)
- Prevention programs for chronic kidney disease in low-income countries (2016) (30)
- Neurological symptoms and coma associated with doxorubicin administration during chronic cyclosporin therapy (1992) (30)
- Thromboxane receptor blockade attenuates the toxic effect of cyclosporine in experimental renal transplantation. (1990) (30)
- In renal transplantation blood cyclosporine levels soon after surgery act as a major determinant of rejection: insights from the MY.S.S. trial. (2004) (30)
- Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage. (1994) (29)
- Abbreviated kinetic profiles in area-under-the-curve monitoring of cyclosporine therapy. Technical note. (1998) (29)
- Mesenchymal stromal cells to promote kidney transplantation tolerance (2014) (29)
- Endothelin antagonists and renal protection. (2000) (29)
- Early and late scanning electron microscopy findings in diabetic kidney disease (2018) (29)
- Dual blockade of the renin-angiotensin system: the ultimate treatment for renal protection? (2005) (29)
- Hyperuricemia in kidney transplantation. (2005) (29)
- Research on renal endothelin in proteinuric nephropathies dictates novel strategies to prevent progression (2001) (28)
- Aging and the kidney (2011) (28)
- Beneficial effects of calcium channel blockade on acute glomerular hemodynamic changes induced by cyclosporine. (1999) (28)
- Generic cyclosporine formulations: more open questions than answers (2005) (28)
- Erratum: Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (The Lancet (2016) 388(10053) (1775–1812)(S0140673616314702)(10.1016/S0140-6736(16)31470-2)) (2017) (27)
- CO‐PARTICIPATION OF THROMBOXANE A2 AND LEUKOTRIENE C4 AND D4 IN MEDIATING CYCLOSPORINE‐INDUCED ACUTE RENAL FAILURE (1991) (27)
- Assessment of sirolimus concentrations in whole blood by high-performance liquid chromatography with ultraviolet detection. (2002) (27)
- Thymic microchimerism correlates with the outcome of tolerance-inducing protocols for solid organ transplantation. (2001) (26)
- Recovery of blood mononuclear cell calcineurin activity segregates two populations of renal transplant patients with different sensitivities to cyclosporine inhibition. (1996) (26)
- Renal transplantation: can we reduce calcineurin inhibitor/stop steroids? Evidence based on protocol biopsy findings. (2003) (26)
- Diabetes mellitus and chronic kidney disease in the Eastern Mediterranean Region: findings from the Global Burden of Disease 2015 study (2017) (25)
- Cyclooxygenase products and atrial natriuretic peptide modulate renal response to endothelin. (1990) (25)
- A logistic-regression model provides novel guidelines to maximize the anti-acute rejection properties of cyclosporine with a minimum of toxicity. (1996) (24)
- Glomerular filtration rate gfr extracellular fluid volume ecv and atrial natriuretic factor anf in insulin dependent diabetics (1988) (24)
- The future of renoprotection. (2005) (23)
- Determination of atazanavir in human plasma by high-performance liquid chromatography with UV detection. (2008) (23)
- Routine renin-angiotensin system blockade in renal transplantation? (2002) (23)
- ACE and SGLT2 inhibitors: the future for non‐diabetic and diabetic proteinuric renal disease (2017) (23)
- Kidney injury molecule 1: in search of biomarkers of chronic tubulointerstitial damage and disease progression. (2009) (23)
- Failure to predict cyclosporine area under the curve using a limited sampling strategy. (1993) (23)
- Glomerular hyperfiltration (2022) (23)
- Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019 (2022) (23)
- Acute kidney injury: more awareness needed, globally (2015) (22)
- Platelet-activating factor alters glomerular barrier size selectivity for macromolecules in rats. (1991) (22)
- Sirtuin3 Dysfunction Is the Key Determinant of Skeletal Muscle Insulin Resistance by Angiotensin II (2015) (22)
- Renal response to atrial peptides is reduced in experimental nephrosis. (1987) (22)
- Prevention of progression and remission/regression strategies for chronic renal diseases: can we do better now than five years ago? (2005) (22)
- Burden of non-communicable diseases among adolescents aged 10–24 years in the EU, 1990–2019: a systematic analysis of the Global Burden of Diseases Study 2019 (2022) (21)
- Aldosterone and progression of kidney disease (2009) (21)
- Eliminating Treatable Deaths Due to Acute Kidney Injury in Resource‐Poor Settings (2015) (21)
- Thymus-mediated immune tolerance to renal allograft is donor but not tissue specific. (1991) (21)
- Platelet-activating factor mediates angiotensin II-induced proteinuria in isolated perfused rat kidney. (1997) (21)
- Safety of Iohexol Administration to Measure Glomerular Filtration Rate in Different Patient Populations: A 25-Year Experience (2018) (20)
- Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019 (2021) (20)
- Non-immune interventions to protect kidney allografts in the long term. (2010) (20)
- Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17 (2020) (20)
- Assessing Renal Function by GFR Prediction Equations in Kidney Transplantation (2005) (20)
- Mortality landscape in the global burden of diseases, injuries and risk factors study. (2014) (20)
- Mesenchymal stromal cells to control donor-specific memory T cells in solid organ transplantation (2015) (20)
- Losartan in diabetic nephropathy (2004) (19)
- Angiotensin II receptor antagonists and treatment of hypertension and renal disease (1998) (19)
- A Home-Treatment Algorithm Based on Anti-inflammatory Drugs to Prevent Hospitalization of Patients With Early COVID-19: A Matched-Cohort Study (COVER 2) (2021) (19)
- Role of platelet-activating factor in renal immune injury and proteinuria. (1990) (18)
- Functional implications of decreased renal cortical atrial natriuretic peptide binding in experimental diabetes. (1990) (18)
- Preventing end-stage renal disease: the potential impact of screening and intervention in developing countries. (2003) (18)
- Renal handling of sodium in the nephrotic syndrome. (1993) (17)
- Comparison of different cyclosporine immunoassays to monitor C0 and C2 blood levels from kidney transplant recipients: not simply overestimation. (2005) (17)
- Intermediate volume on computed tomography imaging defines a fibrotic compartment that predicts glomerular filtration rate decline in autosomal dominant polycystic kidney disease patients. (2011) (17)
- Immunosuppressive therapy abrogates unresponsiveness to renal allograft induced by thymic recognition of donor antigens. (1995) (17)
- Comparison of the Innofluor certican assay with HPLC-UV for the determination of everolimus concentrations in heart transplantation. (2006) (17)
- Acute kidney injury in low-income and middle-income countries: no longer a death sentence. (2016) (17)
- TRANSPLANTS (1968) (17)
- Trends in cardiovascular diseases burden and vascular risk factors in Italy: The Global Burden of Disease study 1990-2017. (2020) (16)
- Pharmacological and clinical profile of valsartan. (1998) (16)
- Management of chronic kidney disease and its risk factors in eastern Nepal. (2014) (16)
- Blocking cell microtubule assembly inhibits the alloimmune response in vitro and prolongs renal allograft survival by inhibition of Th1 and sparing of Th2 cell function in vivo. (1995) (16)
- Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents (2022) (16)
- The potential of endothelin antagonism as a therapeutic approach (2004) (15)
- Evidence of the central role of the thymus in the induction of donor-specific unresponsiveness to a renal allograft. (1992) (15)
- Acquired transplant tolerance (1997) (15)
- Preliminary results of intrathymic injection of donor cells to prevent acute rejection in human heart transplantation. (1995) (15)
- Colchicine allows prolonged survival of highly reactive renal allograft in the rat. (1993) (15)
- Optimization of cyclosporine therapy in the Neoral era: abbreviated AUC, single blood sampling? (2001) (15)
- Prevalence of Hypertension and Diabetes and Coexistence of Chronic Kidney Disease and Cardiovascular Risk in the Population of the Republic of Moldova (2012) (15)
- Kidney transplant tolerance associated with remote autologous mesenchymal stromal cell administration (2019) (14)
- Cyclosporine Formulation and Kaposi’s Sarcoma after Renal Transplantation (2005) (14)
- Prevention and Transplantation in Chronic Kidney Disease: What Is Achievable in Emerging Countries? (2010) (14)
- Efficacy and Tolerability of Valsartan Compared with Lisinopril in Patients with Hypertension and Renal Insufficiency (1997) (14)
- Calcitonin gene-related peptide reduces renal vascular resistance and modulates ET-1-induced vasoconstriction. (1994) (13)
- CTLA4Ig alone or in combination with low-dose cyclosporine fails to reverse acute rejection of renal allograft in the rat. (1996) (13)
- Third‐party bone marrow–derived mesenchymal stromal cell infusion before liver transplantation: A randomized controlled trial (2020) (13)
- Polycystic kidney disease: Do mTOR inhibitors still have a future in ADPKD? (2010) (13)
- Renal metabolism and urinary excretion of platelet-activating factor in the rat. (1990) (13)
- Chronic kidney disease in sub-Saharan Africa: a public health priority. (2014) (12)
- Hypertension and kidney function in an adult population of West Bengal, India: Role of body weight, waist circumference, proteinuria and rural area living (2013) (12)
- Renal handling of aspirin in the rat. (1989) (12)
- Limited Sampling Strategies for the Estimation of Sirolimus Daily Exposure in Kidney Transplant Recipients on a Calcineurin Inhibitor—Free Regimen (2009) (12)
- Renal metabolism and urinary excretion of thromboxane B2 in the rat. (1989) (12)
- Morphometrical analysis of glomerular changes induced by cyclosporine in the rat. (1991) (12)
- Effect of Timing and Complement Receptor Antagonism on Intragraft Recruitment and Pro-Tolerogenic Effects of Mesenchymal Stromal Cells in Murine Kidney Transplantation. (2019) (12)
- Heparin for Hemodialysis: Practical Guidelines for Administration and Monitoring (1984) (12)
- Epidemiology of End-Stage Renal Failure: The Burden of Kidney Diseases to Global Health (2017) (12)
- Prevention of Transplant Rejection (1997) (11)
- Posttransplant immunosuppression in highly sensitized patients. (2009) (11)
- Inhibition of TGF-beta expression: a novel role for thiazolidinediones to implement renoprotection in diabetes. (2007) (11)
- Emerging drugs for diabetic nephropathy (2005) (11)
- Effects of Rosuvastatin on Glomerular Capillary Size-Selectivity Function in Rats with Renal Mass Ablation (2007) (11)
- Pharmacokinetic/pharmacodynamic drug interaction between rosiglitazone and mycophenolate mofetil in kidney transplantation: a case report. (2008) (11)
- FK 506 does not affect the glomerular filtration rate and renal plasma flow in the rat. (1991) (11)
- Acute Kidney Injury in Poor Countries Should No Longer Be a Death Sentence: The ISN ‘0 by 25' Project (2015) (11)
- Bergamo and Covid-19: How the Dark Can Turn to Light (2020) (11)
- Need for chronic kidney disease prevention programs in disadvantaged populations. (2015) (10)
- How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients? (1998) (10)
- Trends in cardiovascular diseases burden and vascular risk factors in Italy: The Global Burden of Disease study 1990-2017. (2021) (10)
- One or two marginal organs for kidney transplantation? (2002) (10)
- International Society of Nephrology's perspective on the emergence of chronic kidney diseases of unknown/undetermined etiology. (2014) (10)
- The Lupus Anticoagulant (1984) (10)
- Immunomodulation by intrathymic injection of donor leukocytes in rhesus monkeys. (2001) (10)
- Pharmacokinetic study of the new cyclosporine-A formulation (Neoral) in adult allogeneic bone marrow transplant recipients. (2001) (10)
- Do attributes of persons with chronic kidney disease differ in low-income and middle-income countries compared with high-income countries? Evidence from population-based data in six countries (2017) (9)
- Xenotransplantation in the 21st Century (2002) (9)
- A RECURRENT QUESTION FROM A PRIMARY CARE PHYSICIAN: HOW SHOULD I TREAT MY COVID-19 PATIENTS AT HOME? (2020) (9)
- The emergence of regenerative medicine in organ transplantation: 1st European Cell Therapy and Organ Regeneration Section meeting (2020) (9)
- Transplantation tolerance. A complex scenario awaiting clinical applicability. (2005) (8)
- Investigational drugs for diabetic nephropathy. (2008) (7)
- Calcineurin inhibitors and sirolimus (2003) (7)
- Renal Graft Function and Low-Dose Cyclosporine Affect Mycophenolic Acid Pharmacokinetics in Kidney Transplantation (2011) (7)
- Proinflammatory mediators of glomerular injury and mechanisms of activation of autoreactive T cells. (1994) (7)
- Blood cyclosporine level soon after kidney transplantation is a major determinant of rejection: insights from the Mycophenolate Steroid-Sparing Trial. (2005) (7)
- Investigational drugs for diabetic nephropathy (2008) (7)
- Studies of privileged sites and organ transplantation. (1993) (7)
- Cyclosporine/tacrolimus (FK-506) (1998) (7)
- Turnour necrosis factor stimulates endothelin-1 gene expression in cultured bovine endothelial cells (1992) (7)
- Abnormalities in arachidonic acid metabolites in nephrotoxic glomerular injury. (1989) (7)
- Renin-angiotensin system and glomerular prostaglandins in early nephrotoxicity of ciclosporin. (1986) (7)
- Mesenchymal Stromal Cells for AKI after Cardiac Surgery. (2017) (7)
- Tacrolimus and ciclosporin microemulsion in renal transplantation (2002) (7)
- Prostacyclin and renal diseases. (1982) (7)
- Metabolism of thromboxane B2 in the isolated perfused rat kidney: mass spectrometric identification of urinary products. (1989) (6)
- Should We Still Believe in Randomized Controlled Trials in Nephrology? (2016) (6)
- Conflict of interest as seen from a researcher’s perspective (2002) (6)
- The scientific care for prevention: an overview. (2005) (6)
- Kidney prevention recipes for your office practice. (2005) (6)
- The possible role of endothelin in the process of progressive renal deterioration in experimental and human glomerulopathies. (1993) (6)
- Therapeutic use of HMG-CoA reductase inhibitors: current practice and future perspectives (2004) (6)
- The Emergence of Regenerative Medicine in Organ Transplantation: 1st ECTORS meeting. (2020) (6)
- The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019 (2022) (6)
- Antiplatelet agents: effects on the progressive renal disease. (1991) (5)
- Intrathymic transplantation of donor cells allows a stabilized, incompatible renal transplant to survive indefinitely after cyclosporine withdrawal. (1993) (5)
- Abnormalities of arachidonate metabolism in experimental ciclosporin nephrotoxicity. (1989) (5)
- Atrial natriuretic factor in hypertensive and normotensive insulin-dependent diabetics. (1989) (5)
- Recent advances in immunosuppression and acquired immune tolerance in renal transplants. (2016) (5)
- Effect of fluid shear stress on tubular kidney epithelial cell structure (2009) (5)
- Drug development: how academia, industry and authorities interact (2014) (5)
- Mycophenolic Acid Formulation Affects Cyclosporine Pharmacokinetics in Stable Kidney Transplant Recipients (2006) (5)
- Pharmacological Induction of Kidney Regeneration (2017) (5)
- Omega-3 polyunsaturated fatty acids affect sirolimus exposure in kidney transplant recipients on calcineurin inhibitor-free regimen. (2010) (4)
- Renal cyclophilin-like protein gene expression parallels changes in sodium excretion in experimental nephrosis and is positively modulated by atrial natriuretic peptide. (1993) (4)
- The incessant search for renal biomarkers: is it really justified? (2019) (4)
- Albuminuria as a risk factor for mild cognitive impairment and dementia—what is the evidence? (2021) (4)
- Pathogenesis of Preeclampsia (1986) (4)
- Immunotolerance: from new knowledge of mechanisms of self-tolerance to future perspectives for induction of renal transplant tolerance. (1995) (4)
- Two-hour post dose cyclosporine monitoring does not fit all in kidney transplantation (2005) (4)
- The Glomerulus: Mechanisms and Patterns of Injury (2014) (4)
- Tertatolol ameliorates renal function in rats with chronic renal failure. (1988) (3)
- ACE inhibition and ANG II receptor blockade improve glomerular size-selectivity in IgA nephropathy. (1999) (3)
- Let's assume that hepatitis C reduces the cardiovascular risk in dialysis patients: are there practical implications? (2006) (3)
- Proteinuria and Tubulotoxicity (2018) (3)
- Epidemiology and outcome - 2 (2009) (3)
- The kidney triggers graft-versus-host disease in experimental combined transplantation of kidney and stem cell-enriched peripheral leukocytes. (1996) (3)
- High serum cholesterol: a missed risk factor for chronic kidney disease mortality. (2014) (3)
- More on renal disease progression: is interstitial inflammation truly protective? (2007) (3)
- A comprehensive report of long-term stability data for a range ATMPs: A need to develop guidelines for safe and harmonized stability studies. (2022) (3)
- Role of thymic- and graft-dependent mechanisms in tolerance induction to rat kidney transplant by donor PBMC infusion. (2007) (3)
- Humoral immunity in kidney transplantation: what clinicians need to know. Preface. (2008) (3)
- [Functional loss of the transplanted kidney: immunological and non-immunological factors]. (2004) (2)
- Optimization of cyclosporine therapy in kidney transplantation. (1998) (2)
- Vascular endothelin and renal disease progression. (1992) (2)
- Section Review Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: New antirejection drugs (1996) (2)
- Conversion from Brand-Name Neoral to the Generic Ciqorin in Stable Renal Transplant Recipients (2016) (2)
- Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Fourth Meeting (2013) (2)
- [Strategies for a greater supply of organs for transplantation]. (2001) (2)
- The Bergamo Kidney Transplant Program. (2005) (2)
- In search of an ideal drug for safer treatment of obesity: The false promise of pseudoephedrine (2021) (2)
- Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial (2023) (2)
- COVID-19 and the Kidney: Should Nephrologists Care about COVID-19 rather than Maintaining Their Focus on Renal Patients? (2021) (2)
- Nitric oxide and renal perfusion in humans. (2002) (2)
- Humoral Immunity in Kidney Trasplantation: What Clinicians Need to Know (2008) (2)
- A comparison of metrics and performance characteristics of different search strategies for article retrieval for a systematic review of the global epidemiology of kidney and urinary diseases (2018) (1)
- Mechanisms and Consequences of Proteinuria (2011) (1)
- Long-Term Outcomes of Kidney Transplants from Older/Marginal Donors: A Cohort Study (2021) (1)
- Effects of tertatolol on renal function in the isolated perfused rat kidney. (1989) (1)
- Induction of unresponsiveness via intrathymic inoculation (1991) (1)
- The role of mTOR inhibition in the control of autosomal dominant polycystic kidney disease (2010) (1)
- The kidney transplant program at the Bergamo Center. (2000) (1)
- Pharmacokinetics and renal function after conversion from standard to microemulsion formulation of cyclosporine in stable renal transplant patients. (1998) (1)
- [Renal transplantation in Autosomal Dominant Polycystic Kidney Disease (ADPKD)]. (2016) (1)
- Generation of Regulatory T Cells Semiallogeneic Heart Transplant through the Cells Prolongs the Survival of a Pretransplant Infusion of Mesenchymal Stem (2008) (1)
- [Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD): Somatostatin analogues and mTOR inhibitors]. (2016) (1)
- Role of endothelin (ET) in the progression of renal disease (1990) (1)
- Effects of Octreotide–Long-Acting Release Added-on Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease: Pilot, Randomized, Placebo-Controlled, Cross-Over Trial (2023) (1)
- Clinical Kidney Xenotransplantation: Major Progress but More Work Needs to Be Done (2022) (1)
- Department of Error (2017) (1)
- MO023FLANK PAIN HAS A MAJOR NEGATIVE IMPACT ON HEALTH-RELATED QUALITY OF LIFE IN ADPKD: THE CYSTIC I STUDY (2021) (1)
- Flank pain has a significant adverse impact on quality of life in ADPKD: the CYSTic-QoL study (2022) (1)
- Octreotide Lar in Patients with Autosomal Dominant Polycystic Kidney Disease: From Bench to A Novel Perspective of Therapy (2022) (1)
- Pharmacogenetics and pharmacogenomics of immunosuppressive agents: perspective for individualized therapy. (2004) (1)
- Prevention of Chronic Renal Diseases in the Elderly (2008) (1)
- Corrigendum to “Let’s assume that hepatitis C reduces the cardiovascular risk in dialysis patients: Are there practical implications?” [J Hepatol 44 (2006) 837–838] (2006) (0)
- The need for a multi-disciplinary reflection about frailty and cognitive impairment in chronic kidney disease (2022) (0)
- Epidemiology and CKD - 3 (2009) (0)
- MYCOPHENOLIC ACID FORMULATIONS AFFECT CYCLOSPORINE PHARMACOKINETICS IN STABLE KIDNEY TRANSPLANT RECIPIENTS. (2006) (0)
- Full-dose NSAIDs at the first sign of respiratory infection? – Authors’ reply (2022) (0)
- Dexamethasone prevents platelet-activating factor induced proteinuria in isolated perfused rat kidney (1995) (0)
- Renal prostaglandins and hyperfiltration. (1987) (0)
- Analysis by fast atom bombardment mass spectrometry of phospholipids from tubuli, glomeruli, and urine of normal rats and rats with acute renal failure. (1992) (0)
- Systemic and Renal Response of GAL-KO Pigs To Human Angiotensin II.: Abstract# D2856 (2014) (0)
- Mesenchymal stromal cell therapy compared to SGLT2-inhibitors and usual care in treating diabetic kidney disease: A cost-effectiveness analysis (2022) (0)
- Low birth weight, nephron number and chronic kidney disease (2022) (0)
- Present and future of CONNECT: a new and compelling project of modern medicine (2021) (0)
- Consultants for the American Journal of Nephrology 2007 (2007) (0)
- Altered Renovascular Endothelial Functions During Nephrotoxicity (1991) (0)
- Acute Renal Failure in Kidney Transplant Recipients (2019) (0)
- Early and late scanning electron microscopy findings in diabetic kidney disease (2018) (0)
- Propionyl-L-carnitine prevents renal ischemia/reperfusion injury in a rat model of syngeneic kidney transplantation (2000) (0)
- Absolute differences between measured and estimated GFR values vs baseline measured GFR. (2012) (0)
- Multipotent Mesenchymal Stromal Cell Therapy and Risk of Malignancies (2012) (0)
- Salty tea intake and hypertension in Mongolia (2009) (0)
- Contents Vol. 136, 2017 (2017) (0)
- Lab methods, progression & risk factors for CKD - 2 (2009) (0)
- Models of human renal disease (1990) (0)
- The Glomerulus: Mechanisms of Injury (2010) (0)
- Effect of ticlopidine on the evolution of renal disease in rats with reduced renal mass. (1990) (0)
- to reduced GFR (2017) (0)
- Tacrolimus and ciclosporin microemulsion in renal transplantation. Author's reply (2002) (0)
- Immune Modulatory Cell Therapy in Kidney Transplantation: Hints of a Durable Mechanism of Action (2023) (0)
- Increased urinary excretion of thromboxane B 2 and 2 , 3-dinor-TxB 2 in cyclosporin A nephrotoxicity (2010) (0)
- MDR1 POLYMORPHISMS INFLUENCES DAILY CYCLOSPORINE EXPOSURE IN STABLE KIDNEY TRANSPLANT RECIPIENTS. (2006) (0)
- LIMITED SAMPLING STRATEGIES FOR THE ESTIMATION OF SIROLIMUS EXPOSURE IN KIDNEY TRANSPLANT RECIPIENTS. (2006) (0)
- RoleofEndothelium-derived Nitric OxideintheBleeding TendencyofUremia (1990) (0)
- Mineral and bone disease - CKD 1-5 (2012) (0)
- Epidemiology and CKD - 2 (2009) (0)
- Epidemiology and CKD - 2 (2009) (0)
- Diffusion magnetic resonance imaging for kidney cyst volume quantification and non-cystic tissue characterisation in ADPKD. (2023) (0)
- Molecular Medicine in Organ Transplantation: How and When? (2001) (0)
- Worldwide cardiovascular and ESRD outcomes attributable to reduced GFR Running Title: Reduced GFR-attributed health loss (2018) (0)
- Semi-Automated Quantification of Cyst Volume from T2-Weighted MR Images in ADPKD (2008) (0)
- Coichicine Interferes with L-Selectin and Leukocyte Function-Associated Antigen-i Expression on Human I Lymphocytes a nd Inhibits I Cell (1996) (0)
- An Artificial Intelligence Algorithm for ADPKD: Are We Close to Successful Clinical Implementation? (2023) (0)
- Pre-clinical studies on end-organ protective effects from AT1-receptor blockade. (2000) (0)
- Addressing acute kidney injury in critically ill newborn babies. (2017) (0)
- Structure and Function in ADPKD: Correlation Between GFR and Relative Volume of Hypo-Enhanced Paranchyma from Contrast-Enhanced CT Imaging (2008) (0)
- Erratum: Correction to Lancet HIV ((2016) 3 (e361–87)(S235230181630087X)(10.1016/S2352-3018(16)30087-X) (2016) (0)
- A Logistic-Regression Model Provides Novel Guidelines to Maximize the Anti-Acute Rejection Properties of Cyclosporine with a Minimum of Toxicity1 (2005) (0)
- Contents Vol. 27, 2007 (2007) (0)
- Links Between Bolivia, Moldova, and Italy for Prevention of Chronic Nephropathies (2005) (0)
- Maintenance Immunosuppression in Kidney Transplantation (2017) (0)
- SAT-148 Determinants of outcomes in pediatric chronic kidney disease [CKD] in a low resource setting (2020) (0)
- Vasoactive and Inflammatory Substances (2004) (0)
- Immunomodulation by intrathymic donor leukocytes in rhesus monkeys (1997) (0)
- Development Donor-Specific Anti-HLA Antibody Associates with a High Incidence of De Novo Depletion and Regeneration , Which Anti-Thymocyte Globulin Induces B Cell but Not Basiliximab / Low-Dose Rabbit In Kidney Transplant Patients , Alemtuzumab (2013) (0)
- Epidemiology and CKD - 1 (2009) (0)
- Pharmacologic Monitoring of Immunosuppressive Drugs (2001) (0)
- Monkeypox in pregnancy: update on (2022) (0)
- Author Correction: Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017 (2020) (0)
- Decreased Nephron Number within Physiologic Ranges Increases Susceptibility to Chronic Renal Diseases Later in Life (2020) (0)
- Pharmacokinetic study of the new cyclosporine-a formulation (neoral™) in adult ALLO-BMT recipients (2000) (0)
- Links Between Bolivia, Moldova and Italy for Prevention of Chronic Nephropathies (2005) (0)
- The lupus anticoagulant (41879) (1984) (0)
- Mechanisms and Mediators of Cyclosporine-Induced Renal Vascular Changes (1991) (0)
- Donor hematopoietic cells: central versus peripheral tolerance (2004) (0)
- Renal transplantation - basic research (2009) (0)
- Editorial: Insights in renal pharmacology: 2021 (2022) (0)
- Subject Index Vol. 27, 2007 (2007) (0)
- Two-hour post-dose cyclosporine monitoring does not fit all in kidney transplantation (2016) (0)
- Subject Index Vol. 162, 2009 (2009) (0)
This paper list is powered by the following services: